Max Healthcare Institute · NSE: MAXHEALTH · BSE: 543220
Q3 FY24 results · Oct–Dec 2023
Max Healthcare Institute reported revenue from operations of ₹1,334.97 crore (up 17.0% from Q3 FY23) and net profit of ₹289.34 crore (up 30.1% from Q3 FY23) for Q3 FY24 (Oct–Dec 2023), on a consolidated basis.
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,334.97 | 1,141.24 | +17.0% | 1,363.16 | −2.1% |
| Other income | 46.02 | 45.15 | +1.9% | 45.48 | +1.2% |
| Total income | 1,380.99 | 1,186.39 | +16.4% | 1,408.64 | −2.0% |
| Profit before tax | 359.68 | 281.44 | +27.8% | 366.42 | −1.8% |
| Net profit for the period | 289.34 | 222.41 | +30.1% | 276.68 | +4.6% |
| EPS, basic (₹) | 2.98 | 2.29 | +30.1% | 2.85 | +4.6% |
| Net margin (%) | 21.7 | 19.5 | 20.3 |
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 590.75 | 481.97 | +22.6% | 596.87 | −1.0% |
| Other income | 42.68 | 44.04 | −3.1% | 48.04 | −11.2% |
| Total income | 633.43 | 526.01 | +20.4% | 644.91 | −1.8% |
| Profit before tax | 203.33 | 157.05 | +29.5% | 210.03 | −3.2% |
| Net profit for the period | 158.12 | 122.14 | +29.5% | 161.31 | −2.0% |
| EPS, basic (₹) | 1.63 | 1.26 | +29.4% | 1.66 | −1.8% |
| Net margin (%) | 26.8 | 25.3 | 27.0 |
Consolidated
- Filed with BSE
- 31 Jan 2024, 17:49 IST
- Board meeting
- 31 Jan 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 31 Jan 2024, 17:49 IST
- Board meeting
- 31 Jan 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE